These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18053120)

  • 41. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
    Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
    Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.
    Johannsson G; Bengtsson BA; Ahlmén J
    Am J Kidney Dis; 1999 Apr; 33(4):709-17. PubMed ID: 10196013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
    Johannsson G; Gordon MB; Højby Rasmussen M; Håkonsson IH; Karges W; Sværke C; Tahara S; Takano K; Biller BMK
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1358-76. PubMed ID: 32022863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
    Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia.
    Bennett RM; Cook DM; Clark SR; Burckhardt CS; Campbell SM
    J Rheumatol; 1997 Jul; 24(7):1384-9. PubMed ID: 9228141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 52. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
    Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
    Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
    McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
    Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and Insulin-like Growth Factor-I Z-scores.
    Oberle M; Grimberg A; Bamba V
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):208-215. PubMed ID: 28150584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole body vibration exercise training for fibromyalgia.
    Bidonde J; Busch AJ; van der Spuy I; Tupper S; Kim SY; Boden C
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011755. PubMed ID: 28950401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency.
    Hoffman AR; Biller BM; Cook D; Baptista J; Silverman BL; Dao L; Attie KM; Fielder P; Maneatis T; Lippe B;
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6431-40. PubMed ID: 16159930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.